Barclays Raises Rating on Oscar Health, Inc. $OSCR
Key Points
- Barclays now rates Oscar Health, Inc. ($OSCR) "buy" with a $35.00 target.
- The Street's average $OSCR price target is $22.60 (Hold).
- $OSCR last traded around $28.50.
Barclays raised its rating on Oscar Health, Inc. ($OSCR) to a "buy" rating, with a price target of $35.00 in a recent research note.
Oscar Health, Inc. ($OSCR) Stock
Oscar Health, Inc. Earnings
Analysts Set New Price Targets
About Oscar Health, Inc.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.